From: High performance methylated DNA markers for detection of colon adenocarcinoma
Tissue | Training set | Test set | Plasma | Pilot set |
---|---|---|---|---|
Colon ca. (N) | 30 | 33 | Colorectal ca. (N) | 20 |
 Age at surgery (years) |  |  |  Age (years) |  |
  Mean | 69 | 69 |   Mean | 56 |
  Median | 68 | 69 |   Median | 58 |
  Range | 55–86 | 56–85 |   Range | 40–68 |
 Sex (N) |  |  |   Sex (N) |  |
  Male | 11 | 19 |   Male | 11 |
  Female | 19 | 14 |   Female | 9 |
 Tumor cellularity (N) | ||||
  0–40% | 2 | 1 |  |  |
  ≥ 40–70% | 17 | 16 |  |  |
  ≥ 70% | 11 | 16 |  |  |
 Stage |  |  |  Stage |  |
  I | 7 | 11 |   I | 0 |
  II | 11 | 15 |   II | 0 |
  III | 12 | 7 |   III | 0 |
  IV | 0 | 0 |   IV | 20 |
 Location |  |  |  Location of Primary |  |
  Colon ascendens | 14 | 18 |   Colon ascendens | 9 |
  Colon transversum | 1 | 2 |   Colon transversum | 0 |
  Colon descendens | 3 | 3 |   Colon descendens | 2 |
  Sigmoid | 11 | 10 |   Sigmoid | 7 |
  Rectum | 0 | 0 |   Rectum | 2 |
  Not available | 1 | 0 |   Not available | 0 |
 % Treated (N) |  |  |  |  |
  Neoadjuvant | 0 (0) | 0 (0) |  |  |
  Adjuvant | 38.7 (12) | 20.6 (7) |  |  |
 Normal, adjacent (N) | 23 | 20 |  Normal (N) | 20 |
Age at surgery (years) | Â | Â | Age (years) | Â |
  Mean | 66 | 65 |   Mean | 70 |
  Median | 65 | 65 |   Median | 70 |
  Range | 55–86 | 56–85 |   Range | 26–97 |
 Sex (N) |  |  |  Sex (N) |  |
  Male | 11 | 10 |   Male | 13 |
  Female | 12 | 10 |   Female | 7 |